{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:16:08Z","timestamp":1794021368358,"version":"4.8.0"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020771","name":"Young Scientists Fund of the  National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32200655"],"award-info":[{"award-number":["32200655"]}],"id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of the intracranial internal carotid arteries and the development of compensatory, fragile collateral vascular networks at the skull. Emerging evidence suggests that the pathogenesis of MMD involves genetic\/epigenetic predisposition, dysregulated immune responses, and environmental triggers. Notably, the RNF213 p.R4810K variant has been identified as a key genetic susceptibility factor, particularly in East Asian populations. However, the molecular mechanisms underlying disease progression remain incompletely elucidated, primarily due to the limited availability of patient-derived cerebrovascular tissues and the lack of animal models that faithfully recapitulate the full spectrum of human MMD pathology. These constraints have impeded the development of targeted therapeutic interventions. Diagnostically, digital subtraction angiography (DSA) continues to serve as the gold standard for diagnosing MMD, enabling detailed visualization of steno-occlusive lesions and characteristic moyamoya vessels. Current clinical management relies predominantly on surgical revascularization to enhance cerebral perfusion, yet this strategy does not alter the fundamental disease process. Recent advances in patient-derived vascular organoids and serum-stimulated cellular models have facilitated drug screening and biomarker identification. In this review, we provide a systematic overview of the epidemiology, clinical manifestations, and genetic landscape of MMD, with a focus on recent progress in deciphering its molecular basis. We further discuss the transformative potential of induced pluripotent stem cell (iPSC) technology, particularly when combined with CRISPR-based gene editing, for modeling MMD vasculopathy, investigating the functional impact of RNF213 mutations, and exploring precision repair approaches. These innovative approaches offer novel insights into disease mechanisms and open new avenues for therapeutic intervention in MMD.<\/jats:p>","DOI":"10.1186\/s43556-025-00318-y","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:47:37Z","timestamp":1760064457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Moyamoya disease: epidemiology, clinical features, pathogenesis, diagnosis and therapeutic interventions"],"prefix":"10.1186","volume":"6","author":[{"given":"Xinyue","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoudong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-3815","authenticated-orcid":false,"given":"Yuqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"318_CR1","doi-asserted-by":"publisher","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u201399. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012.","DOI":"10.1001\/archneur.1969.00480090076012"},{"issue":"6","key":"318_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","volume":"65","author":"K Uchino","year":"2005","unstructured":"Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65(6):956\u20138. https:\/\/doi.org\/10.1212\/01.wnl.0000176066.33797.82.","journal-title":"Neurology"},{"issue":"8","key":"318_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/s1474-4422(22)00165-x","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):747\u201358. https:\/\/doi.org\/10.1016\/s1474-4422(22)00165-x.","journal-title":"Lancet Neurol"},{"issue":"6","key":"318_CR4","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3171\/2011.3.Focus1151","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus. 2011;30(6):E20. https:\/\/doi.org\/10.3171\/2011.3.Focus1151.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"318_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311. https:\/\/doi.org\/10.5853\/jos.2015.01627.","journal-title":"J Stroke"},{"issue":"2","key":"318_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1570159x19666210716114016","volume":"20","author":"X Zhang","year":"2022","unstructured":"Zhang X, Xiao W, Zhang Q, Xia D, Gao P, Su J, et al. Progression in Moyamoya disease: clinical features, neuroimaging evaluation, and treatment. Curr Neuropharmacol. 2022;20(2):292\u2013308. https:\/\/doi.org\/10.2174\/1570159x19666210716114016.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"318_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","volume":"13","author":"R Mertens","year":"2022","unstructured":"Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, et al. The genetic basis of Moyamoya disease. Transl Stroke Res. 2022;13(1):25\u201345. https:\/\/doi.org\/10.1007\/s12975-021-00940-2.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"318_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132.","journal-title":"J Hum Genet"},{"key":"318_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/life12040555","author":"T Hiraide","year":"2022","unstructured":"Hiraide T, Suzuki H, Momoi M, Shinya Y, Fukuda K, Kosaki K, et al. RNF213-associated vascular disease: a concept unifying various vasculopathies. Life. 2022. https:\/\/doi.org\/10.3390\/life12040555.","journal-title":"Life"},{"issue":"4","key":"318_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","volume":"53","author":"V Roy","year":"2022","unstructured":"Roy V, Ross JP, P\u00e9pin R, Cortez Ghio S, Brodeur A, Touzel Desch\u00eanes L, et al. Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function. Stroke. 2022;53(4):1263\u201375. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032691.","journal-title":"Stroke"},{"issue":"11","key":"318_CR11","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1007\/s12035-023-03480-y","volume":"60","author":"W Li","year":"2023","unstructured":"Li W, Niu X, Dai Y, Wu X, Li J, Sheng W. Rnf-213 knockout induces pericyte reduction and blood-brain barrier impairment in mouse. Mol Neurobiol. 2023;60(11):6188\u2013200. https:\/\/doi.org\/10.1007\/s12035-023-03480-y.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"318_CR12","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1038\/s41467-024-50392-z","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Zhu X, Sheng J, Fu Y, Nie D, You X, et al. Rnf213 promotes Treg cell differentiation by facilitating K63-linked ubiquitination and nuclear translocation of FOXO1. Nat Commun. 2024;15(1):5961. https:\/\/doi.org\/10.1038\/s41467-024-50392-z.","journal-title":"Nat Commun"},{"issue":"11","key":"318_CR13","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye F, Niu X, Liang F, Dai Y, Liang J, Li J, et al. Rnf213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain. 2023;146(11):4674\u201389. https:\/\/doi.org\/10.1093\/brain\/awad225.","journal-title":"Brain"},{"issue":"4","key":"318_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1647","volume":"14","author":"P Ge","year":"2024","unstructured":"Ge P, Tao C, Wang W, He Q, Liu C, Zheng Z, et al. Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease. Clin Transl Med. 2024;14(4):e1647. https:\/\/doi.org\/10.1002\/ctm2.1647.","journal-title":"Clin Transl Med"},{"issue":"11","key":"318_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28(11):939\u201350. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009.","journal-title":"Trends Mol Med"},{"issue":"1","key":"318_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, et al. CRISPR\/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther. 2023;8(1):36. https:\/\/doi.org\/10.1038\/s41392-023-01309-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"318_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","volume":"20","author":"RG Rowe","year":"2019","unstructured":"Rowe RG, Daley GQ. Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet. 2019;20(7):377\u201388. https:\/\/doi.org\/10.1038\/s41576-019-0100-z.","journal-title":"Nat Rev Genet"},{"key":"318_CR18","doi-asserted-by":"publisher","unstructured":"Singh A, Irfan H, Fatima E, Nazir Z, Verma A, Akilimali A. Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR\/Cas9 gene therapy for sickle cell disease. Annals of medicine and surgery (2012). 2024;86(8):4555\u20139. https:\/\/doi.org\/10.1097\/ms9.0000000000002146.","DOI":"10.1097\/ms9.0000000000002146"},{"issue":"4","key":"318_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000345957","volume":"40","author":"D Kainth","year":"2013","unstructured":"Kainth D, Chaudhry SA, Kainth H, Suri FK, Qureshi AI. Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology. 2013;40(4):282\u20137. https:\/\/doi.org\/10.1159\/000345957.","journal-title":"Neuroepidemiology"},{"issue":"Suppl 2","key":"318_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/s0303-8467(97)00031-0","volume":"99","author":"K Wakai","year":"1997","unstructured":"Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99(Suppl 2):S1-5. https:\/\/doi.org\/10.1016\/s0303-8467(97)00031-0.","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"318_CR21","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1161\/strokeaha.111.622522","volume":"42","author":"JY Yeon","year":"2011","unstructured":"Yeon JY, Shin HJ, Kong DS, Seol HJ, Kim JS, Hong SC, et al. The prediction of contralateral progression in children and adolescents with unilateral moyamoya disease. Stroke. 2011;42(10):2973\u20136. https:\/\/doi.org\/10.1161\/strokeaha.111.622522.","journal-title":"Stroke"},{"issue":"2","key":"318_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000356350","volume":"37","author":"KI Jo","year":"2014","unstructured":"Jo KI, Yeon JY, Hong SC, Kim JS. Clinical course of asymptomatic adult moyamoya disease. Cerebrovasc Dis. 2014;37(2):94\u2013101. https:\/\/doi.org\/10.1159\/000356350.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"318_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","volume":"43","author":"S Shang","year":"2020","unstructured":"Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, et al. Progress in moyamoya disease. Neurosurg Rev. 2020;43(2):371\u201382. https:\/\/doi.org\/10.1007\/s10143-018-0994-5.","journal-title":"Neurosurg Rev"},{"issue":"1","key":"318_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/strokeaha.107.490714","volume":"39","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39(1):42\u20137. https:\/\/doi.org\/10.1161\/strokeaha.107.490714.","journal-title":"Stroke"},{"issue":"8","key":"318_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900\u20134. https:\/\/doi.org\/10.1136\/jnnp.2007.130666.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"318_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","volume":"112","author":"W Miao","year":"2010","unstructured":"Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, et al. Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg. 2010;112(3):199\u2013203. https:\/\/doi.org\/10.1016\/j.clineuro.2009.11.009.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"318_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/strokeaha.113.004273","volume":"45","author":"IM Ahn","year":"2014","unstructured":"Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke. 2014;45(4):1090\u20135. https:\/\/doi.org\/10.1161\/strokeaha.113.004273.","journal-title":"Stroke"},{"issue":"6","key":"318_CR28","doi-asserted-by":"publisher","first-page":"e2415102","DOI":"10.1001\/jamanetworkopen.2024.15102","volume":"7","author":"YC Lim","year":"2024","unstructured":"Lim YC, Lee E, Song J. Outcomes of bypass surgery in adult Moyamoya disease by onset type. JAMA Netw Open. 2024;7(6):e2415102. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.15102.","journal-title":"JAMA Netw Open"},{"key":"318_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/B978-0-12-803058-5.00109-0","volume-title":"Primer on Cerebrovascular Diseases","author":"JS Kim","year":"2017","unstructured":"Kim JS, et al. Chapter 109 - Moyamoya Disease and Syndrome. In: Caplan LR, Biller J, Leary MC, Lo EH, Thomas AJ, Yenari M, et al., editors. Primer on Cerebrovascular Diseases. 2nd ed. San Diego: Academic Press; 2017. p. 561\u20136.","edition":"2"},{"key":"318_CR30","doi-asserted-by":"publisher","unstructured":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurologia medico-chirurgica. 2012;52(5):245\u201366. https:\/\/doi.org\/10.2176\/nmc.52.245.","DOI":"10.2176\/nmc.52.245"},{"key":"318_CR31","doi-asserted-by":"crossref","unstructured":"Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99 Suppl 2:S238\u201340.","DOI":"10.1016\/S0303-8467(97)00082-6"},{"key":"318_CR32","unstructured":"Zhou Xiwei WJ, and Ma Yan. Literature evaluation and current situation of moyamoya disease in China. Chinese Journal of Practical Neurological Diseases. 2017;20(10):1\u20134."},{"issue":"1","key":"318_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/strokeaha.111.621300","volume":"43","author":"L Duan","year":"2012","unstructured":"Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012;43(1):56\u201360. https:\/\/doi.org\/10.1161\/strokeaha.111.621300.","journal-title":"Stroke"},{"issue":"2","key":"318_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014;16(2):65\u201372. https:\/\/doi.org\/10.5853\/jos.2014.16.2.65.","journal-title":"J Stroke"},{"issue":"2","key":"318_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/302243","volume":"64","author":"H Ikeda","year":"1999","unstructured":"Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64(2):533\u20137. https:\/\/doi.org\/10.1086\/302243.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"318_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2176\/nmc.52.267","volume":"52","author":"K Houkin","year":"2012","unstructured":"Houkin K, Ito M, Sugiyama T, Shichinohe H, Nakayama N, Kazumata K, et al. Review of past research and current concepts on the etiology of moyamoya disease. Neurol Med Chir. 2012;52(5):267\u201377. https:\/\/doi.org\/10.2176\/nmc.52.267.","journal-title":"Neurol Med Chir"},{"issue":"4","key":"318_CR37","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.str.31.4.930","volume":"31","author":"T Yamauchi","year":"2000","unstructured":"Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31(4):930\u20135. https:\/\/doi.org\/10.1161\/01.str.31.4.930.","journal-title":"Stroke"},{"issue":"24 Pt 2","key":"318_CR38","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1212\/01.wnl.0000291012.49986.f9","volume":"70","author":"Y Mineharu","year":"2008","unstructured":"Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70(24 Pt 2):2357\u201363. https:\/\/doi.org\/10.1212\/01.wnl.0000291012.49986.f9.","journal-title":"Neurology"},{"issue":"7","key":"318_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6(7):e22542. https:\/\/doi.org\/10.1371\/journal.pone.0022542.","journal-title":"PLoS ONE"},{"issue":"1","key":"318_CR40","doi-asserted-by":"publisher","first-page":"22720","DOI":"10.1038\/s41598-024-72043-5","volume":"14","author":"A Nakamura","year":"2024","unstructured":"Nakamura A, Nomura S, Hara S, Thamamongood T, Maehara T, Nariai T, et al. Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome. Sci Rep. 2024;14(1):22720. https:\/\/doi.org\/10.1038\/s41598-024-72043-5.","journal-title":"Sci Rep"},{"key":"318_CR41","doi-asserted-by":"publisher","unstructured":"disease WgfCecsotdatom. Chinese expert consensus statement on the diagnosis and treatment of moyamoya disease. Chinese Neurosurgical Journal. 2024;40:220\u20139. https:\/\/doi.org\/10.3760\/cma.j.cn112050-20231119-00177.","DOI":"10.3760\/cma.j.cn112050-20231119-00177"},{"issue":"21","key":"318_CR42","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1097\/cm9.0000000000002985","volume":"137","author":"J Fang","year":"2024","unstructured":"Fang J, Yang X, Ni J. RNF213 in moyamoya disease: genotype-phenotype association and the underlying mechanism. Chin Med J. 2024;137(21):2552\u201360. https:\/\/doi.org\/10.1097\/cm9.0000000000002985.","journal-title":"Chin Med J"},{"key":"318_CR43","doi-asserted-by":"publisher","unstructured":"Zhang Q, Liu Y, Yu L, Duan R, Ma Y, Ge P et al. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature. World neurosurgery. 2017;99:701\u20138.\u00a0https:\/\/doi.org\/10.1016\/j.wneu.2016.12.119.","DOI":"10.1016\/j.wneu.2016.12.119"},{"issue":"4","key":"318_CR44","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2016.2.Jns152173","volume":"126","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, et al. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126(4):1106\u201313. https:\/\/doi.org\/10.3171\/2016.2.Jns152173.","journal-title":"J Neurosurg"},{"issue":"5","key":"318_CR45","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.Jns142900","volume":"124","author":"EH Kim","year":"2016","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016;124(5):1221\u20137. https:\/\/doi.org\/10.3171\/2015.4.Jns142900.","journal-title":"J Neurosurg"},{"key":"318_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.001862","author":"Y Moteki","year":"2015","unstructured":"Moteki Y, Onda H, Kasuya H, Yoneyama T, Okada Y, Hirota K, et al. Systematic validation of RNF213 coding variants in Japanese patients with Moyamoya Disease. J Am Heart Assoc. 2015. https:\/\/doi.org\/10.1161\/jaha.115.001862.","journal-title":"J Am Heart Assoc"},{"key":"318_CR47","doi-asserted-by":"publisher","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803\u201310. https:\/\/doi.org\/10.1212\/WNL.0b013e318249f71f.","DOI":"10.1212\/WNL.0b013e318249f71f"},{"issue":"1","key":"318_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12199-017-0680-1","volume":"22","author":"X Liao","year":"2017","unstructured":"Liao X, Deng J, Dai W, Zhang T, Yan J. Rare variants of RNF213 and moyamoya\/non-moyamoya intracranial artery stenosis\/occlusion disease risk: a meta-analysis and systematic review. Environ Health Prev Med. 2017;22(1):75. https:\/\/doi.org\/10.1186\/s12199-017-0680-1.","journal-title":"Environ Health Prev Med"},{"issue":"11","key":"318_CR49","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/strokeaha.114.006244","volume":"45","author":"AC Cecchi","year":"2014","unstructured":"Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, et al. Rnf213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke. 2014;45(11):3200\u20137. https:\/\/doi.org\/10.1161\/strokeaha.114.006244.","journal-title":"Stroke"},{"issue":"2","key":"318_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.23736\/s0390-5616.16.03900-x","volume":"64","author":"A Raso","year":"2020","unstructured":"Raso A, Biassoni R, Mascelli S, Nozza P, Ugolotti E, Di Marco E, et al. Moyamoya vasculopathy shows a genetic mutational gradient decreasing from east to west. J Neurosurg Sci. 2020;64(2):165\u201372. https:\/\/doi.org\/10.23736\/s0390-5616.16.03900-x.","journal-title":"J Neurosurg Sci"},{"key":"318_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41439-019-0066-6","volume":"6","author":"AN Gagunashvili","year":"2019","unstructured":"Gagunashvili AN, Ocaka L, Kelberman D, Munot P, Bacchelli C, Beales PL, et al. Novel missense variants in the RNF213 gene from a European family with Moyamoya disease. Hum Genome Var. 2019;6:35. https:\/\/doi.org\/10.1038\/s41439-019-0066-6.","journal-title":"Hum Genome Var"},{"issue":"13","key":"318_CR52","doi-asserted-by":"publisher","first-page":"e1783","DOI":"10.1212\/wnl.0000000000011653","volume":"96","author":"A Pinard","year":"2021","unstructured":"Pinard A, Fiander MDJ, Cecchi AC, Rideout AL, Azouz M, Fraser SM, et al. Association of de novo RNF213 variants with childhood onset Moyamoya disease and diffuse occlusive vasculopathy. Neurology. 2021;96(13):e1783\u201391. https:\/\/doi.org\/10.1212\/wnl.0000000000011653.","journal-title":"Neurology"},{"issue":"8","key":"318_CR53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaneurol.2021.1681","volume":"78","author":"AJ Kundishora","year":"2021","unstructured":"Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, et al. DIAPH1 variants in non-East Asian patients with sporadic moyamoya disease. JAMA Neurol. 2021;78(8):993\u20131003. https:\/\/doi.org\/10.1001\/jamaneurol.2021.1681.","journal-title":"JAMA Neurol"},{"issue":"3","key":"318_CR54","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3892\/etm.2019.7198","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019;17(3):1977\u201384. https:\/\/doi.org\/10.3892\/etm.2019.7198.","journal-title":"Exp Ther Med"},{"issue":"1","key":"318_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000540254","volume":"14","author":"S Uchiyama","year":"2024","unstructured":"Uchiyama S, Fujimura M. Adult moyamoya disease and moyamoya syndrome: what is new? Cerebrovasc Dis Extra. 2024;14(1):86\u201394. https:\/\/doi.org\/10.1159\/000540254.","journal-title":"Cerebrovasc Dis Extra"},{"issue":"2","key":"318_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00381-004-0962-y","volume":"21","author":"P Horn","year":"2005","unstructured":"Horn P, Bueltmann E, Buch CV, Schmiedek P. Arterio-embolic ischemic stroke in children with moyamoya disease. Childs Nerv Syst. 2005;21(2):104\u20137. https:\/\/doi.org\/10.1007\/s00381-004-0962-y.","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"318_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.str.14.1.104","volume":"14","author":"J Suzuki","year":"1983","unstructured":"Suzuki J, Kodama N. Moyamoya disease\u2013a review. Stroke. 1983;14(1):104\u20139. https:\/\/doi.org\/10.1161\/01.str.14.1.104.","journal-title":"Stroke"},{"issue":"1","key":"318_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jnnp.2008.145078","volume":"80","author":"JM Kim","year":"2009","unstructured":"Kim JM, Lee SH, Roh JK. Changing ischaemic lesion patterns in adult moyamoya disease. J Neurol Neurosurg Psychiatry. 2009;80(1):36\u201340. https:\/\/doi.org\/10.1136\/jnnp.2008.145078.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"318_CR59","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3171\/2013.6.Jns122099","volume":"119","author":"T Hishikawa","year":"2013","unstructured":"Hishikawa T, Tokunaga K, Sugiu K, Date I. Assessment of the difference in posterior circulation involvement between pediatric and adult patients with moyamoya disease. J Neurosurg. 2013;119(4):961\u20135. https:\/\/doi.org\/10.3171\/2013.6.Jns122099.","journal-title":"J Neurosurg"},{"issue":"6","key":"318_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3340\/jkns.2015.57.6.436","volume":"57","author":"JY Lee","year":"2015","unstructured":"Lee JY, Kim SK, Phi JH, Wang KC. Posterior cerebral artery insufficiency in pediatric Moyamoya disease. J Korean Neurosurg Soc. 2015;57(6):436\u20139. https:\/\/doi.org\/10.3340\/jkns.2015.57.6.436.","journal-title":"J Korean Neurosurg Soc"},{"issue":"4","key":"318_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/BF00270916","volume":"4","author":"Y Maki","year":"1988","unstructured":"Maki Y, Enomoto T. Moyamoya disease. Childs Nerv Syst. 1988;4(4):204\u201312. https:\/\/doi.org\/10.1007\/BF00270916.","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"318_CR62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.braindev.2010.09.003","volume":"33","author":"J Takanashi","year":"2011","unstructured":"Takanashi J. Moyamoya disease in children. Brain Dev. 2011;33(3):229\u201334. https:\/\/doi.org\/10.1016\/j.braindev.2010.09.003.","journal-title":"Brain Dev"},{"issue":"11","key":"318_CR63","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/s1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056\u201366. https:\/\/doi.org\/10.1016\/s1474-4422(08)70240-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"318_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ana.21981","volume":"68","author":"SK Kim","year":"2010","unstructured":"Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol. 2010;68(1):92\u2013101. https:\/\/doi.org\/10.1002\/ana.21981.","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"318_CR65","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1046\/j.1440-1789.2000.00300.x","volume":"20","author":"M Fukui","year":"2000","unstructured":"Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology. 2000;20(Suppl):S61\u20134. https:\/\/doi.org\/10.1046\/j.1440-1789.2000.00300.x.","journal-title":"Neuropathology"},{"issue":"3","key":"318_CR66","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00006123-200203000-00022","volume":"50","author":"SG Soriano","year":"2002","unstructured":"Soriano SG, Cowan DB, Proctor MR, Scott RM. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with Moyamoya Syndrome. Neurosurgery. 2002;50(3):544\u20139. https:\/\/doi.org\/10.1097\/00006123-200203000-00022.","journal-title":"Neurosurgery"},{"issue":"6","key":"318_CR67","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3171\/jns.1994.81.6.0843","volume":"81","author":"K Ikezaki","year":"1994","unstructured":"Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg. 1994;81(6):843\u201350. https:\/\/doi.org\/10.3171\/jns.1994.81.6.0843.","journal-title":"J Neurosurg"},{"issue":"12","key":"318_CR68","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1017\/s001216220500174x","volume":"47","author":"AM Hogan","year":"2005","unstructured":"Hogan AM, Kirkham FJ, Isaacs EB, Wade AM, Vargha-Khadem F. Intellectual decline in children with moyamoya and sickle cell anaemia. Dev Med Child Neurol. 2005;47(12):824\u20139. https:\/\/doi.org\/10.1017\/s001216220500174x.","journal-title":"Dev Med Child Neurol"},{"issue":"5 Suppl","key":"318_CR69","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3171\/ped.2005.103.5.0439","volume":"103","author":"HJ Seol","year":"2005","unstructured":"Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK. Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg. 2005;103(5 Suppl):439\u201342. https:\/\/doi.org\/10.3171\/ped.2005.103.5.0439.","journal-title":"J Neurosurg"},{"issue":"3","key":"318_CR70","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3171\/2011.11.Jns11944","volume":"116","author":"Y Okada","year":"2012","unstructured":"Okada Y, Kawamata T, Kawashima A, Yamaguchi K, Ono Y, Hori T. The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg. 2012;116(3):672\u20139. https:\/\/doi.org\/10.3171\/2011.11.Jns11944.","journal-title":"J Neurosurg"},{"issue":"5","key":"318_CR71","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000350203","volume":"35","author":"W Sun","year":"2013","unstructured":"Sun W, Yuan C, Liu W, Li Y, Huang Z, Zhu W, et al. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up. Cerebrovasc Dis. 2013;35(5):469\u201375. https:\/\/doi.org\/10.1159\/000350203.","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"318_CR72","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/RLI.0b013e31817fb432","volume":"43","author":"N Mori","year":"2008","unstructured":"Mori N, Miki Y, Kikuta K, Fushimi Y, Okada T, Urayama S, et al. Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol. 2008;43(8):574\u20139. https:\/\/doi.org\/10.1097\/RLI.0b013e31817fb432.","journal-title":"Invest Radiol"},{"key":"318_CR73","doi-asserted-by":"publisher","unstructured":"Kikuta K, Takagi Y, Nozaki K, Sawamoto N, Fukuyama H, Hashimoto N. The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery. 2008;62(1):104\u201311, discussion 11\u20132. https:\/\/doi.org\/10.1227\/01.Neu.0000311067.41239.E6.","DOI":"10.1227\/01.Neu.0000311067.41239.E6"},{"key":"318_CR74","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000807","author":"A Bhardwaj","year":"2022","unstructured":"Bhardwaj A, Banh RS, Zhang W, Sidhu SS, Neel BG. MMD-associated RNF213 SNPs encode dominant-negative alleles that globally impair ubiquitylation. Life Sci Alliance. 2022. https:\/\/doi.org\/10.26508\/lsa.202000807.","journal-title":"Life Sci Alliance"},{"key":"318_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094492","author":"G Pollaci","year":"2022","unstructured":"Pollaci G, Gorla G, Potenza A, Carrozzini T, Canavero I, Bersano A, et al. Novel multifaceted roles for RNF213 protein. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094492.","journal-title":"Int J Mol Sci"},{"key":"318_CR76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuroscience.2023.09.018","volume":"533","author":"S Li","year":"2023","unstructured":"Li S, Li Y, Huang P, Mao X, Jiang K, Chen R, et al. Knockout of Rnf213 ameliorates cerebral ischemic-reperfusion injury by inhibiting neuronal apoptosis through the Akt\/GSK-3\u03b2\/\u03b2-catenin\/Bcl-2 pathway. Neuroscience. 2023;533:10\u201321. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.09.018.","journal-title":"Neuroscience"},{"issue":"1","key":"318_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, et al. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun. 2013;438(1):13\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2013.07.004.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"318_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16473","volume":"31","author":"J Xu","year":"2024","unstructured":"Xu J, Zou Z, Liu W, Zhang Q, Shen J, Hao F, et al. HAPLN3 p. T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K. Eur J Neurol. 2024;31(12):e16473. https:\/\/doi.org\/10.1111\/ene.16473.","journal-title":"Eur J Neurol"},{"issue":"5","key":"318_CR79","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","volume":"84","author":"DC Guo","year":"2009","unstructured":"Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84(5):617\u201327. https:\/\/doi.org\/10.1016\/j.ajhg.2009.04.007.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"318_CR80","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","volume":"88","author":"S Miskinyte","year":"2011","unstructured":"Miskinyte S, Butler MG, Herv\u00e9 D, Sarret C, Nicolino M, Petralia JD, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011;88(6):718\u201328. https:\/\/doi.org\/10.1016\/j.ajhg.2011.04.017.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"318_CR81","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.003","volume":"26","author":"M Mukawa","year":"2017","unstructured":"Mukawa M, Nariai T, Onda H, Yoneyama T, Aihara Y, Hirota K, et al. Exome sequencing identified CCER2 as a novel candidate gene for moyamoya disease. J Stroke Cerebrovasc Dis. 2017;26(1):150\u201361. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.09.003.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"318_CR82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/cge.12739","volume":"90","author":"S Wallace","year":"2016","unstructured":"Wallace S, Guo DC, Regalado E, Mellor-Crummey L, Bamshad M, Nickerson DA, et al. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clin Genet. 2016;90(4):351\u201360. https:\/\/doi.org\/10.1111\/cge.12739.","journal-title":"Clin Genet"},{"key":"318_CR83","doi-asserted-by":"publisher","unstructured":"Lei Cao YS, Zhizhong Zhang, Chenchao Wang, Kaiwen Sun, Yang Dong, Dongming Yan, Hongwei Li, Bo Yang. Bioinformatics Analysis of Moyamoya Disease and Moyamoya Syndrome Pathology Based on Genetic Genes. Chinese Joumal of Cerebrovascular Diseases(Electronic Edition). 2024;18(04):350\u20136. https:\/\/doi.org\/10.11817\/j.issn.1673-9248.2024.04.009.","DOI":"10.11817\/j.issn.1673-9248.2024.04.009"},{"issue":"11","key":"318_CR84","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1172\/jci40924","volume":"119","author":"J Loscalzo","year":"2009","unstructured":"Loscalzo J. Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology. J Clin Investig. 2009;119(11):3203\u20135. https:\/\/doi.org\/10.1172\/jci40924.","journal-title":"J Clin Investig"},{"issue":"11 pt 2","key":"318_CR85","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.36740\/WLek202211224","volume":"75","author":"A Gospodarczyk","year":"2022","unstructured":"Gospodarczyk A, Marczewski K, Gospodarczyk N, Widuch M, Tkocz M, Zalejska-Fiolka J. Homocysteine and cardiovascular disease - a current review. Wiad Lek. 2022;75(11 pt 2):2862\u20136. https:\/\/doi.org\/10.36740\/WLek202211224.","journal-title":"Wiad Lek"},{"issue":"3","key":"318_CR86","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5853\/jos.2018.00962","volume":"20","author":"HY Sung","year":"2018","unstructured":"Sung HY, Lee JY, Park AK, Moon YJ, Jo I, Park EM, et al. Aberrant promoter hypomethylation of Sortilin 1: a Moyamoya disease biomarker. J Stroke. 2018;20(3):350\u201361. https:\/\/doi.org\/10.5853\/jos.2018.00962.","journal-title":"J Stroke"},{"key":"318_CR87","doi-asserted-by":"publisher","first-page":"7192060","DOI":"10.1155\/2022\/7192060","volume":"2022","author":"S He","year":"2022","unstructured":"He S, Ye X, Duan R, Zhao Y, Wei Y, Wang Y, et al. Epigenome-Wide Association Study Reveals Differential Methylation Sites and Association of Gene Expression Regulation with Ischemic Moyamoya Disease in Adults. Oxid Med Cell Longev. 2022;2022:7192060. https:\/\/doi.org\/10.1155\/2022\/7192060.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"318_CR88","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41598-021-81282-9","volume":"11","author":"M Matsuo","year":"2021","unstructured":"Matsuo M, Nadanaka S, Soga M, Sugiyama T, Serigano S, Shimano K, et al. Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease. Sci Rep. 2021;11(1):1552. https:\/\/doi.org\/10.1038\/s41598-021-81282-9.","journal-title":"Sci Rep"},{"issue":"6","key":"318_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70367","volume":"15","author":"S He","year":"2025","unstructured":"He S, Zhou Z, Liang R, Lei C, Liu Y, Yuan J, et al. DNA methylation profiles reveals STAB1-mediated endothelial cell and immune cell interactions in Moyamoya disease. Clin Transl Med. 2025;15(6):e70367. https:\/\/doi.org\/10.1002\/ctm2.70367.","journal-title":"Clin Transl Med"},{"issue":"4","key":"318_CR90","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s12975-024-01299-w","volume":"16","author":"K Tokairin","year":"2025","unstructured":"Tokairin K, Ito M, Lee AG, Teo M, He S, Cheng MY, et al. Genome-wide DNA methylation profiling reveals low methylation variability in Moyamoya disease. Transl Stroke Res. 2025;16(4):1198\u2013213. https:\/\/doi.org\/10.1007\/s12975-024-01299-w.","journal-title":"Transl Stroke Res"},{"issue":"7","key":"318_CR91","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/atvbaha.115.305363","volume":"35","author":"JY Lee","year":"2015","unstructured":"Lee JY, Moon YJ, Lee HO, Park AK, Choi SA, Wang KC, et al. Deregulation of retinaldehyde dehydrogenase 2 leads to defective angiogenic function of endothelial colony-forming cells in pediatric Moyamoya disease. Arterioscler Thromb Vasc Biol. 2015;35(7):1670\u20137. https:\/\/doi.org\/10.1161\/atvbaha.115.305363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"318_CR92","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41436-019-0639-2","volume":"22","author":"A Pinard","year":"2020","unstructured":"Pinard A, Guey S, Guo D, Cecchi AC, Kharas N, Wallace S, et al. The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. Genet Med. 2020;22(2):427\u201331. https:\/\/doi.org\/10.1038\/s41436-019-0639-2.","journal-title":"Genet Med"},{"issue":"24","key":"318_CR93","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/circulationaha.116.022478","volume":"134","author":"D Hartmann","year":"2016","unstructured":"Hartmann D, Fiedler J, Sonnenschein K, Just A, Pfanne A, Zimmer K, et al. Microrna-based therapy of GATA2-deficient vascular disease. Circulation. 2016;134(24):1973\u201390. https:\/\/doi.org\/10.1161\/circulationaha.116.022478.","journal-title":"Circulation"},{"issue":"13","key":"318_CR94","doi-asserted-by":"publisher","first-page":"13234","DOI":"10.18632\/aging.103431","volume":"12","author":"C Chen","year":"2020","unstructured":"Chen C, Ling C, Gong J, Li C, Zhang L, Gao S, et al. Increasing the expression of microRNA-126-5p in the temporal muscle can promote angiogenesis in the chronically ischemic brains of rats subjected to two-vessel occlusion plus encephalo-myo-synangiosis. Aging (Albany NY). 2020;12(13):13234\u201354. https:\/\/doi.org\/10.18632\/aging.103431.","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"318_CR95","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.01.041","volume":"24","author":"S Zhao","year":"2015","unstructured":"Zhao S, Gong Z, Zhang J, Xu X, Liu P, Guan W, et al. Elevated serum MicroRNA Let-7c in Moyamoya disease. J Stroke Cerebrovasc Dis. 2015;24(8):1709\u201314. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.01.041.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"318_CR96","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.wneu.2016.05.081","volume":"93","author":"F Gao","year":"2016","unstructured":"Gao F, Yu L, Zhang D, Zhang Y, Wang R, Zhao J. Long noncoding RNAs and their regulatory network: potential therapeutic targets for adult Moyamoya disease. World Neurosurg. 2016;93:111\u20139. https:\/\/doi.org\/10.1016\/j.wneu.2016.05.081.","journal-title":"World Neurosurg"},{"issue":"12","key":"318_CR97","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1161\/strokeaha.123.044476","volume":"54","author":"S He","year":"2023","unstructured":"He S, Zhang J, Liu Z, Wang Y, Hao X, Wang X, et al. Upregulated cytoskeletal proteins promote pathological angiogenesis in Moyamoya disease. Stroke. 2023;54(12):3153\u201364. https:\/\/doi.org\/10.1161\/strokeaha.123.044476.","journal-title":"Stroke"},{"key":"318_CR98","doi-asserted-by":"publisher","unstructured":"He S, Zhou Z, Cheng MY, Hao X, Chiang T, Wang Y et al. Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions. MedComm (2020). 2025;6(2):e70054. https:\/\/doi.org\/10.1002\/mco2.70054.","DOI":"10.1002\/mco2.70054"},{"key":"318_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233792","author":"Y Liu","year":"2022","unstructured":"Liu Y, Huang Y, Zhang X, Ma X, He X, Gan C, et al. CircZXDC promotes vascular smooth muscle cell transdifferentiation via regulating miRNA-125a-3p\/ABCC6 in Moyamoya disease. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11233792.","journal-title":"Cells"},{"issue":"2","key":"318_CR100","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10143-019-01086-4","volume":"43","author":"T Mikami","year":"2020","unstructured":"Mikami T, Suzuki H, Ukai R, Komatsu K, Akiyama Y, Wanibuchi M, et al. Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease. Neurosurg Rev. 2020;43(2):609\u201317. https:\/\/doi.org\/10.1007\/s10143-019-01086-4.","journal-title":"Neurosurg Rev"},{"issue":"6","key":"318_CR101","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3346\/jkms.2003.18.6.876","volume":"18","author":"H Han","year":"2003","unstructured":"Han H, Pyo CW, Yoo DS, Huh PW, Cho KS, Kim DS. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci. 2003;18(6):876\u201380. https:\/\/doi.org\/10.3346\/jkms.2003.18.6.876.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"318_CR102","first-page":"44","volume":"12","author":"E Ikeda","year":"1993","unstructured":"Ikeda E, Hosoda Y. Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: cerebrovascular moyamoya disease. Clin Neuropathol. 1993;12(1):44\u20138.","journal-title":"Clin Neuropathol"},{"key":"318_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030823","author":"W Liu","year":"2023","unstructured":"Liu W, Sun J, Shi Z, Huang Z, Yu L, Du H, et al. Circulating inflammatory cytokine associated with poor prognosis in Moyamoya disease: a prospective cohort study. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12030823.","journal-title":"J Clin Med"},{"key":"318_CR104","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.wneu.2017.01.012","volume":"100","author":"JC Mejia-Munne","year":"2017","unstructured":"Mejia-Munne JC, Ellis JA, Feldstein NA, Meyers PM, Connolly ES. Moyamoya and inflammation. World Neurosurg. 2017;100:575\u20138. https:\/\/doi.org\/10.1016\/j.wneu.2017.01.012.","journal-title":"World Neurosurg"},{"issue":"2","key":"318_CR105","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2269368","volume":"55","author":"W Liu","year":"2023","unstructured":"Liu W, Liu C, Yu X, Zhai Y, He Q, Li J, et al. Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study. Ann Med. 2023;55(2):2269368. https:\/\/doi.org\/10.1080\/07853890.2023.2269368.","journal-title":"Ann Med"},{"key":"318_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15020137","author":"S Wang","year":"2025","unstructured":"Wang S, Jiang Q, Liu Y, Zhang X, Huang Y, Zhang H. The role of immune cells in Moyamoya disease. Brain Sci. 2025. https:\/\/doi.org\/10.3390\/brainsci15020137.","journal-title":"Brain Sci"},{"issue":"10","key":"318_CR107","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","volume":"59","author":"T Mikami","year":"2019","unstructured":"Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of inflammatory disease on the pathophysiology of Moyamoya disease and quasi-moyamoya disease. Neurol Med Chir. 2019;59(10):361\u201370. https:\/\/doi.org\/10.2176\/nmc.ra.2019-0059.","journal-title":"Neurol Med Chir"},{"key":"318_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.735416","volume":"11","author":"L Martina","year":"2021","unstructured":"Martina L, Asselman C, Thery F, Boucher K, Delhaye L, Maia TM, et al. Proteome profiling of RNF213 depleted cells reveals nitric oxide regulator DDAH1 antilisterial activity. Front Cell Infect Microbiol. 2021;11:735416. https:\/\/doi.org\/10.3389\/fcimb.2021.735416.","journal-title":"Front Cell Infect Microbiol"},{"issue":"13","key":"318_CR109","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1161\/01.cir.97.13.1274","volume":"97","author":"S Janssens","year":"1998","unstructured":"Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C, et al. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation. 1998;97(13):1274\u201381. https:\/\/doi.org\/10.1161\/01.cir.97.13.1274.","journal-title":"Circulation"},{"key":"318_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.661611","volume":"14","author":"KB Dorschel","year":"2023","unstructured":"Dorschel KB, Wanebo JE. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. Front Neurol. 2023;14:661611. https:\/\/doi.org\/10.3389\/fneur.2023.661611.","journal-title":"Front Neurol"},{"issue":"1","key":"318_CR111","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5505\/ejm.2024.87003","volume":"29","author":"G G\u00fcnerhan","year":"2024","unstructured":"G\u00fcnerhan G, \u00d6cal \u00d6, \u00c7a\u011fil E, Da\u011flar Z, Karaman A, G\u00fcnd\u00fcz UK, et al. Unraveling oxidative stress in Moyamoya disease: exploring thiol-disulfide dynamics and ischemia-modified albumin. Eastern J Med. 2024;29(1):39\u201346. https:\/\/doi.org\/10.5505\/ejm.2024.87003.","journal-title":"Eastern J Med"},{"issue":"1","key":"318_CR112","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1161\/STROKEAHA.123.045064","volume":"55","author":"X Ruan","year":"2024","unstructured":"Ruan X, Lei T, Xiang X, Liu F, Shi Xe. Insights on Moyamoya disease: vascular inflammation and nuclear autoschizis in cranial arteries. Stroke. 2024;55(1):e5\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.123.045064.","journal-title":"Stroke"},{"key":"318_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021082","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS. The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25021082.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"318_CR114","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","volume":"525","author":"M Takeda","year":"2020","unstructured":"Takeda M, Tezuka T, Kim M, Choi J, Oichi Y, Kobayashi H, et al. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03bab activation and apoptosis in an AAA+ domain-dependent manner. Biochem Biophys Res Commun. 2020;525(3):668\u201374. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.024.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"318_CR115","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1007\/s10753-024-02201-4","volume":"48","author":"C Liu","year":"2025","unstructured":"Liu C, Mou S, Zhang B, Pang Y, Chan L, Li J, et al. Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients with Moyamoya Disease. Inflammation. 2025;48(4):2444\u201357. https:\/\/doi.org\/10.1007\/s10753-024-02201-4.","journal-title":"Inflammation"},{"issue":"8045","key":"318_CR116","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-024-08136-y","volume":"637","author":"A Bhardwaj","year":"2025","unstructured":"Bhardwaj A, Panepinto MC, Ueberheide B, Neel BG. A mechanism for hypoxia-induced inflammatory cell death in cancer. Nature. 2025;637(8045):470\u20137. https:\/\/doi.org\/10.1038\/s41586-024-08136-y.","journal-title":"Nature"},{"issue":"12","key":"318_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1492","volume":"13","author":"S He","year":"2023","unstructured":"He S, Wang Y, Liu Z, Zhang J, Hao X, Wang X, et al. Metabolomic signatures associated with pathological angiogenesis in moyamoya disease. Clin Transl Med. 2023;13(12):e1492. https:\/\/doi.org\/10.1002\/ctm2.1492.","journal-title":"Clin Transl Med"},{"key":"318_CR118","doi-asserted-by":"publisher","first-page":"1417329","DOI":"10.3389\/fgene.2024.1417329","volume":"15","author":"Z Han","year":"2024","unstructured":"Han Z, Zhang J, Su Y, Zhou Z, Wang Y, Xu S, et al. Identification of oxidative phosphorylation-related genes in moyamoya disease by combining bulk RNA-sequencing analysis and machine learning. Front Genet. 2024;15:1417329. https:\/\/doi.org\/10.3389\/fgene.2024.1417329.","journal-title":"Front Genet"},{"issue":"11","key":"318_CR119","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1177\/0271678x18768443","volume":"38","author":"KG Blecharz-Lang","year":"2018","unstructured":"Blecharz-Lang KG, Prinz V, Burek M, Frey D, Schenkel T, Krug SM, et al. Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease. J Cereb Blood Flow Metab. 2018;38(11):1940\u201353. https:\/\/doi.org\/10.1177\/0271678x18768443.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"318_CR120","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10143-024-02448-3","volume":"47","author":"Z Li","year":"2024","unstructured":"Li Z, Liu Y, Li X, Yang S, Feng S, Li G, et al. Knockdown the moyamoya disease susceptibility gene, RNF213, upregulates the expression of basic fibroblast growth factor and matrix metalloproteinase-9 in bone marrow derived mesenchymal stem cells. Neurosurg Rev. 2024;47(1):246. https:\/\/doi.org\/10.1007\/s10143-024-02448-3.","journal-title":"Neurosurg Rev"},{"issue":"2","key":"318_CR121","doi-asserted-by":"publisher","first-page":"73","DOI":"10.31083\/j.rcm2302073","volume":"23","author":"J Zhang","year":"2022","unstructured":"Zhang J. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Rev Cardiovasc Med. 2022;23(2):73. https:\/\/doi.org\/10.31083\/j.rcm2302073.","journal-title":"Rev Cardiovasc Med"},{"issue":"18","key":"318_CR122","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/wnr.0000000000000289","volume":"25","author":"S Sonobe","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, Fujimura T, Furudate S, Nishijima Y, et al. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene. NeuroReport. 2014;25(18):1442\u20136. https:\/\/doi.org\/10.1097\/wnr.0000000000000289.","journal-title":"NeuroReport"},{"key":"318_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041696","author":"YC Fang","year":"2021","unstructured":"Fang YC, Wei LF, Hu CJ, Tu YK. Pathological circulating factors in Moyamoya disease. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22041696.","journal-title":"Int J Mol Sci"},{"key":"318_CR124","doi-asserted-by":"publisher","unstructured":"Takagi Y, Kikuta K, Nozaki K, Fujimoto M, Hayashi J, Imamura H et al. Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease. Neurosurgery. 2007;60(2):338\u201345; discussion 45. https:\/\/doi.org\/10.1227\/01.Neu.0000249275.87310.Ff.","DOI":"10.1227\/01.Neu.0000249275.87310.Ff"},{"issue":"11","key":"318_CR125","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.molmed.2022.09.004","volume":"28","author":"Y Hu","year":"2022","unstructured":"Hu Y, Lu H, Li H, Ge J. Molecular basis and clinical implications of HIFs in cardiovascular diseases. Trends Mol Med. 2022;28(11):916\u201338. https:\/\/doi.org\/10.1016\/j.molmed.2022.09.004.","journal-title":"Trends Mol Med"},{"issue":"2","key":"318_CR126","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1152\/japplphysiol.00772.2016","volume":"122","author":"SK Nishiyama","year":"2017","unstructured":"Nishiyama SK, Zhao J, Wray DW, Richardson RS. Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction. J Appl Physiol (1985). 2017;122(2):354\u201360. https:\/\/doi.org\/10.1152\/japplphysiol.00772.2016.","journal-title":"J Appl Physiol (1985)"},{"issue":"7861","key":"318_CR127","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-021-03566-4","volume":"594","author":"EG Otten","year":"2021","unstructured":"Otten EG, Werner E, Crespillo-Casado A, Boyle KB, Dharamdasani V, Pathe C, et al. Ubiquitylation of lipopolysaccharide by RNF213 during bacterial infection. Nature. 2021;594(7861):111\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03566-4.","journal-title":"Nature"},{"key":"318_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.881954","volume":"15","author":"S Xu","year":"2022","unstructured":"Xu S, Wei W, Zhang F, Chen T, Dong L, Shi J, et al. Transcriptomic profiling of intracranial arteries in adult patients with Moyamoya disease reveals novel insights into its pathogenesis. Front Mol Neurosci. 2022;15:881954. https:\/\/doi.org\/10.3389\/fnmol.2022.881954.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"318_CR129","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909\u201350. https:\/\/doi.org\/10.1152\/physrev.00026.2013.","journal-title":"Physiol Rev"},{"key":"318_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101867","volume":"41","author":"H Sies","year":"2021","unstructured":"Sies H. Oxidative eustress: on constant alert for redox homeostasis. Redox Biol. 2021;41:101867. https:\/\/doi.org\/10.1016\/j.redox.2021.101867.","journal-title":"Redox Biol"},{"issue":"1","key":"318_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03479-3","volume":"22","author":"C Liu","year":"2025","unstructured":"Liu C, Li J, Mou S, Pang Y, Chan L, He Q, et al. Circulating T cell atlas in Moyamoya disease: insights into immunopathogenesis of cerebrovascular disorders. J Neuroinflammation. 2025;22(1):151. https:\/\/doi.org\/10.1186\/s12974-025-03479-3.","journal-title":"J Neuroinflammation"},{"key":"318_CR132","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.reprotox.2017.07.002","volume":"73","author":"M Ibrahim","year":"2017","unstructured":"Ibrahim M, Richardson MK. Beyond organoids: In vitro vasculogenesis and angiogenesis using cells from mammals and zebrafish. Reproductive toxicology (Elmsford, NY). 2017;73:292\u2013311. https:\/\/doi.org\/10.1016\/j.reprotox.2017.07.002.","journal-title":"Reproductive toxicology (Elmsford, NY)"},{"key":"318_CR133","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.brainres.2015.07.039","volume":"1624","author":"A Kanoke","year":"2015","unstructured":"Kanoke A, Fujimura M, Niizuma K, Ito A, Sakata H, Sato-Maeda M, et al. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease. Brain Res. 2015;1624:497\u2013505. https:\/\/doi.org\/10.1016\/j.brainres.2015.07.039.","journal-title":"Brain Res"},{"issue":"12","key":"318_CR134","first-page":"1845","volume":"116","author":"M Rao","year":"2003","unstructured":"Rao M, Zhang H, Liu Q, Zhang S, Hu L, Deng F. Clinical and experimental pathology of Moyamoya disease. Chin Med J. 2003;116(12):1845\u20139.","journal-title":"Chin Med J"},{"issue":"3","key":"318_CR135","doi-asserted-by":"publisher","first-page":"143","DOI":"10.18926\/amo\/32831","volume":"57","author":"I Kamata","year":"2003","unstructured":"Kamata I, Terai Y, Ohmoto T. Attempt to establish an experimental animal model of moyamoya disease using immuno-embolic material\u2013histological changes of the arterial wall resulting from immunological reaction in cats. Acta Med Okayama. 2003;57(3):143\u201350. https:\/\/doi.org\/10.18926\/amo\/32831.","journal-title":"Acta Med Okayama"},{"key":"318_CR136","unstructured":"Suzuki J, Kodama N, Mineura K. [Etiological studies of cerebrovascular Moyamoya disease]. No to shinkei = Brain and nerve. 1976;28(5):459\u201370."},{"issue":"3","key":"318_CR137","first-page":"251","volume":"10","author":"N Kasai","year":"1982","unstructured":"Kasai N, Fujiwara S, Kodama N, Yonemitsu T, Suzuki J. The experimental study on causal genesis of moyamoya disease - correlation with immunological reaction and sympathetic nerve influence for vascular changes (author\u2019s transl). No shinkei geka Neurological surgery. 1982;10(3):251\u201361.","journal-title":"No shinkei geka Neurological surgery"},{"issue":"6","key":"318_CR138","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3171\/2008.6.Peds0834","volume":"3","author":"M Nakamura","year":"2009","unstructured":"Nakamura M, Imai H, Konno K, Kubota C, Seki K, Puentes S, et al. Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. J Neurosurg Pediatr. 2009;3(6):488\u201395. https:\/\/doi.org\/10.3171\/2008.6.Peds0834.","journal-title":"J Neurosurg Pediatr"},{"key":"318_CR139","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2016.04.051","volume":"1644","author":"J Wen","year":"2016","unstructured":"Wen J, Sun X, Chen H, Liu H, Lai R, Li J, et al. Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res. 2016;1644:70\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2016.04.051.","journal-title":"Brain Res"},{"issue":"1","key":"318_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191312","volume":"13","author":"JM Roberts","year":"2018","unstructured":"Roberts JM, Maniskas ME, Fraser JF, Bix GJ. Internal carotid artery stenosis: a novel surgical model for moyamoya syndrome. PLoS ONE. 2018;13(1):e0191312. https:\/\/doi.org\/10.1371\/journal.pone.0191312.","journal-title":"PLoS ONE"},{"issue":"3","key":"318_CR141","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1747493017694393","volume":"12","author":"S Huang","year":"2017","unstructured":"Huang S, Guo ZN, Shi M, Yang Y, Rao M. Etiology and pathogenesis of Moyamoya disease: an update on disease prevalence. Int J Stroke. 2017;12(3):246\u201353. https:\/\/doi.org\/10.1177\/1747493017694393.","journal-title":"Int J Stroke"},{"key":"318_CR142","doi-asserted-by":"publisher","unstructured":"Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, et al. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease. Brain Res. 2014;1552:64\u201371. https:\/\/doi.org\/10.1016\/j.brainres.2014.01.011.","DOI":"10.1016\/j.brainres.2014.01.011"},{"key":"318_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2016.03.009","volume":"1642","author":"A Kanoke","year":"2016","unstructured":"Kanoke A, Fujimura M, Niizuma K, Fujimura T, Kakizaki A, Ito A, et al. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease. Brain Res. 2016;1642:1\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2016.03.009.","journal-title":"Brain Res"},{"key":"318_CR144","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.brainres.2014.11.014","volume":"1594","author":"A Ito","year":"2015","unstructured":"Ito A, Fujimura M, Niizuma K, Kanoke A, Sakata H, Morita-Fujimura Y, et al. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease. Brain Res. 2015;1594:310\u201320. https:\/\/doi.org\/10.1016\/j.brainres.2014.11.014.","journal-title":"Brain Res"},{"key":"318_CR145","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.002146","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, et al. Biochemical and functional characterization of RNF213 (mysterin) R4810K, a susceptibility mutation of Moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc. 2015. https:\/\/doi.org\/10.1161\/jaha.115.002146.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"318_CR146","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1038\/s41598-018-22064-8","volume":"8","author":"T Morimoto","year":"2018","unstructured":"Morimoto T, Enmi JI, Hattori Y, Iguchi S, Saito S, Harada KH, et al. Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci Rep. 2018;8(1):3607. https:\/\/doi.org\/10.1038\/s41598-018-22064-8.","journal-title":"Sci Rep"},{"issue":"suppl_1","key":"318_CR147","doi-asserted-by":"publisher","first-page":"AWP282","DOI":"10.1161\/str.48.suppl_1.wp282","volume":"48","author":"Z Starosolski","year":"2017","unstructured":"Starosolski Z, Wright J, Milewicz D, Annapragada A. Abstract WP282: gender-dependent differences in the cerebrovascular system in wildtype mice and cerebrovascular lesions in a mouse model of Moyamoya disease. Stroke. 2017;48(suppl_1):AWP282-AWP. https:\/\/doi.org\/10.1161\/str.48.suppl_1.wp282.","journal-title":"Stroke"},{"key":"318_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105339","volume":"154","author":"X Ren","year":"2021","unstructured":"Ren X, Yao LL, Pan JX, Zhang JS, Mei L, Wang YG, et al. Linking cortical astrocytic neogenin deficiency to the development of Moyamoya disease-like vasculopathy. Neurobiol Dis. 2021;154:105339. https:\/\/doi.org\/10.1016\/j.nbd.2021.105339.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"318_CR149","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3171\/2024.11.Jns241804","volume":"143","author":"S He","year":"2025","unstructured":"He S, Zhang J, Zhou Z, Wang Y, Wang X, Niu H, et al. Serum amyloid A2-induced phenotypic switching of vascular smooth muscle cells in moyamoya disease. J Neurosurg. 2025;143(2):530\u201342. https:\/\/doi.org\/10.3171\/2024.11.Jns241804.","journal-title":"J Neurosurg"},{"issue":"7","key":"318_CR150","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1177\/0271678x231162184","volume":"43","author":"S He","year":"2023","unstructured":"He S, Liang J, Xue G, Wang Y, Zhao Y, Liu Z, et al. RNA profiling of sEV (small extracellular vesicles)\/exosomes reveals biomarkers and vascular endothelial dysplasia with moyamoya disease. J Cereb Blood Flow Metab. 2023;43(7):1194\u2013205. https:\/\/doi.org\/10.1177\/0271678x231162184.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"318_CR151","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1024\/0301-1526\/a000363","volume":"43","author":"Q Chen","year":"2014","unstructured":"Chen Q, Qi R, Cheng X, Zhou C, Luo S, Ni L, et al. Assessment of extracranial-intracranial bypass in Moyamoya disease using 3T time-of-flight MR angiography: comparison with CT angiography. Vasa. 2014;43(4):278\u201383. https:\/\/doi.org\/10.1024\/0301-1526\/a000363.","journal-title":"Vasa"},{"issue":"5","key":"318_CR152","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.01.014","volume":"22","author":"T Sugino","year":"2013","unstructured":"Sugino T, Mikami T, Ohtaki S, Hirano T, Iihoshi S, Houkin K, et al. Assessment of moyamoya disease using multidetector row computed tomography. J Stroke Cerebrovasc Dis. 2013;22(5):644\u20139. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2012.01.014.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"318_CR153","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00330-012-2751-4","volume":"23","author":"A Han","year":"2013","unstructured":"Han A, Yoon DY, Kim ES, Kim HC, Cho BM, Lee JY. Value of CT angiography for the detection of intracranial vascular lesions in patients with acute severe headache. Eur Radiol. 2013;23(6):1443\u20139. https:\/\/doi.org\/10.1007\/s00330-012-2751-4.","journal-title":"Eur Radiol"},{"issue":"2","key":"318_CR154","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1054\/jocn.1999.0160","volume":"7","author":"N Saeki","year":"2000","unstructured":"Saeki N, Silva MN, Kubota M, Takanashi J, Sugita K, Nakazaki S, et al. Comparative performance of magnetic resonance angiography and conventional angiography in moyamoya disease. J Clin Neurosci. 2000;7(2):112\u20135. https:\/\/doi.org\/10.1054\/jocn.1999.0160.","journal-title":"J Clin Neurosci"},{"issue":"11","key":"318_CR155","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1161\/strokeaha.110.598565","volume":"42","author":"P Pandey","year":"2011","unstructured":"Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42(11):3304\u201310. https:\/\/doi.org\/10.1161\/strokeaha.110.598565.","journal-title":"Stroke"},{"issue":"6","key":"318_CR156","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s002340050433","volume":"39","author":"K Noguchi","year":"1997","unstructured":"Noguchi K, Ogawa T, Inugami A, Fujita H, Hatazawa J, Shimosegawa E, et al. MRI of acute cerebral infarction: a comparison of FLAIR and T2-weighted fast spin-echo imaging. Neuroradiology. 1997;39(6):406\u201310. https:\/\/doi.org\/10.1007\/s002340050433.","journal-title":"Neuroradiology"},{"issue":"2","key":"318_CR157","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1148\/radiol.2021203568","volume":"299","author":"P Liu","year":"2021","unstructured":"Liu P, Liu G, Pinho MC, Lin Z, Thomas BP, Rundle M, et al. Cerebrovascular reactivity mapping using resting-state BOLD functional MRI in healthy adults and patients with Moyamoya disease. Radiology. 2021;299(2):419\u201325. https:\/\/doi.org\/10.1148\/radiol.2021203568.","journal-title":"Radiology"},{"issue":"9921","key":"318_CR158","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/s0140-6736(13)61088-0","volume":"383","author":"AI Qureshi","year":"2014","unstructured":"Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet. 2014;383(9921):984\u201398. https:\/\/doi.org\/10.1016\/s0140-6736(13)61088-0.","journal-title":"Lancet"},{"key":"318_CR159","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/b978-0-7020-4086-3.00031-x","volume":"119","author":"HP Adams Jr","year":"2014","unstructured":"Adams HP Jr. Cerebral vasculitis. Handb Clin Neurol. 2014;119:475\u201394. https:\/\/doi.org\/10.1016\/b978-0-7020-4086-3.00031-x.","journal-title":"Handb Clin Neurol"},{"issue":"18","key":"318_CR160","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMra032393","volume":"350","author":"DP Slovut","year":"2004","unstructured":"Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350(18):1862\u201371. https:\/\/doi.org\/10.1056\/NEJMra032393.","journal-title":"N Engl J Med"},{"issue":"5","key":"318_CR161","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/17474930241297031","volume":"20","author":"N Rifino","year":"2025","unstructured":"Rifino N, Herv\u00e8 D, Acerbi F, Kuroda S, Lanzino G, Vajkoczy P, et al. Diagnosis and management of adult Moyamoya angiopathy: an overview of guideline recommendations and identification of future research directions. Int J Stroke. 2025;20(5):512\u201323. https:\/\/doi.org\/10.1177\/17474930241297031.","journal-title":"Int J Stroke"},{"issue":"2","key":"318_CR162","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/rct.0000000000000834","volume":"43","author":"J Li","year":"2019","unstructured":"Li J, Jin M, Sun X, Li J, Liu Y, Xi Y, et al. Imaging of Moyamoya disease and Moyamoya syndrome: current status. J Comput Assist Tomogr. 2019;43(2):257\u201363. https:\/\/doi.org\/10.1097\/rct.0000000000000834.","journal-title":"J Comput Assist Tomogr"},{"key":"318_CR163","unstructured":"Zhang JG, Liu KL, Zhao LH, Qian WQ, Peng WL, Liu Y et al. [Comparison of MR Perfusion Weighted Imaging and CT Perfusion Imaging in Assessing Hemodynamics of Patients with Moyamoya Disease]. Sichuan da xue xue bao Yi xue ban = Journal of Sichuan University Medical science edition. 2018;49(5):749\u201353."},{"issue":"1","key":"318_CR164","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41016-024-00358-3","volume":"10","author":"P Ge","year":"2024","unstructured":"Ge P, Yin Z, Tao C, Zeng C, Yu X, Lei S, et al. Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS). Chin Neurosurg J. 2024;10(1):5. https:\/\/doi.org\/10.1186\/s41016-024-00358-3.","journal-title":"Chin Neurosurg J"},{"key":"318_CR165","doi-asserted-by":"publisher","unstructured":"He Q, Li J, Tao C, Zeng C, Liu C, Zheng Z et al. High glutamine increases stroke risk by inducing the endothelial-to-mesenchymal transition in moyamoya disease. MedComm (2020). 2024;5(5):e525. https:\/\/doi.org\/10.1002\/mco2.525.","DOI":"10.1002\/mco2.525"},{"key":"318_CR166","unstructured":"(edited). DL. Suzuki staging of moyamoya disease [J]. Chinese Journal of Neurosurgery. 2012;28(05):477."},{"issue":"11","key":"318_CR167","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11332","volume":"12","author":"J Mayeku","year":"2020","unstructured":"Mayeku J, Lopez-Gonzalez MA. Current Surgical Options for Moyamoya Disease. Cureus. 2020;12(11):e11332. https:\/\/doi.org\/10.7759\/cureus.11332.","journal-title":"Cureus"},{"issue":"CN_suppl_1","key":"318_CR168","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/neuros\/nyy114","volume":"65","author":"X Deng","year":"2018","unstructured":"Deng X, Ge P, Wang S, Zhang D, Zhang Y, Wang R, et al. Treatment of moyamoya disease. Neurosurgery. 2018;65(CN_suppl_1):62\u20135. https:\/\/doi.org\/10.1093\/neuros\/nyy114.","journal-title":"Neurosurgery"},{"issue":"1","key":"318_CR169","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho WS. Moyamoya disease: treatment and outcomes. J Stroke. 2016;18(1):21\u201330. https:\/\/doi.org\/10.5853\/jos.2015.01739.","journal-title":"J Stroke"},{"issue":"5","key":"318_CR170","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3171\/jns.1978.49.5.0679","volume":"49","author":"J Karasawa","year":"1978","unstructured":"Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T. Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg. 1978;49(5):679\u201388. https:\/\/doi.org\/10.3171\/jns.1978.49.5.0679.","journal-title":"J Neurosurg"},{"issue":"6","key":"318_CR171","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3340\/jkns.2015.57.6.390","volume":"57","author":"T Kim","year":"2015","unstructured":"Kim T, Lee H, Bang JS, Kwon OK, Hwang G, Oh CW. Epidemiology of Moyamoya disease in Korea: based on National Health Insurance Service data. J Korean Neurosurg Soc. 2015;57(6):390\u20135. https:\/\/doi.org\/10.3340\/jkns.2015.57.6.390.","journal-title":"J Korean Neurosurg Soc"},{"issue":"6","key":"318_CR172","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3171\/2015.6.Jns151105","volume":"124","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Kwon OK, Hwang G, Kim JE, Kang HS, et al. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg. 2016;124(6):1788\u201393. https:\/\/doi.org\/10.3171\/2015.6.Jns151105.","journal-title":"J Neurosurg"},{"issue":"10","key":"318_CR173","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1161\/strokeaha.114.005624","volume":"45","author":"WS Cho","year":"2014","unstructured":"Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, et al. Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke. 2014;45(10):3025\u201331. https:\/\/doi.org\/10.1161\/strokeaha.114.005624.","journal-title":"Stroke"},{"issue":"7","key":"318_CR174","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.053","volume":"24","author":"EJ Arias","year":"2015","unstructured":"Arias EJ, Dunn GP, Washington CW, Derdeyn CP, Chicoine MR, Grubb RL Jr., et al. Surgical revascularization in North American adults with Moyamoya phenomenon: long-term angiographic follow-up. J Stroke Cerebrovasc Dis. 2015;24(7):1597\u2013608. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.03.053.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"318_CR175","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2011.6.Peds10578","volume":"8","author":"JH Phi","year":"2011","unstructured":"Phi JH, Wang KC, Cho BK, Lee MS, Lee JH, Yu KS, et al. Long-term social outcome in children with moyamoya disease who have reached adulthood. J Neurosurg Pediatr. 2011;8(3):303\u20139. https:\/\/doi.org\/10.3171\/2011.6.Peds10578.","journal-title":"J Neurosurg Pediatr"},{"issue":"2 Suppl Pediatr","key":"318_CR176","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3171\/ped.2004.100.2.0142","volume":"100","author":"RM Scott","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100(2 Suppl Pediatrics):142\u20139. https:\/\/doi.org\/10.3171\/ped.2004.100.2.0142.","journal-title":"J Neurosurg"},{"issue":"1","key":"318_CR177","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00701-013-1921-8","volume":"156","author":"SC Lee","year":"2014","unstructured":"Lee SC, Jeon JS, Kim JE, Chung YS, Ahn JH, Cho WS, et al. Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir (Wien). 2014;156(1):103\u201311. https:\/\/doi.org\/10.1007\/s00701-013-1921-8.","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"318_CR178","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/strokeaha.106.478297","volume":"38","author":"S Kuroda","year":"2007","unstructured":"Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38(5):1430\u20135. https:\/\/doi.org\/10.1161\/strokeaha.106.478297.","journal-title":"Stroke"},{"issue":"1","key":"318_CR179","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/2014.9.Jns132281","volume":"122","author":"WS Cho","year":"2015","unstructured":"Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, et al. The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg. 2015;122(1):82\u20139. https:\/\/doi.org\/10.3171\/2014.9.Jns132281.","journal-title":"J Neurosurg"},{"issue":"1\u20132","key":"318_CR180","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jns.2015.11.018","volume":"359","author":"HJ Noh","year":"2015","unstructured":"Noh HJ, Kim SJ, Kim JS, Hong SC, Kim KH, Jun P, et al. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease. J Neurol Sci. 2015;359(1\u20132):381\u20138. https:\/\/doi.org\/10.1016\/j.jns.2015.11.018.","journal-title":"J Neurol Sci"},{"key":"318_CR181","doi-asserted-by":"publisher","unstructured":"Bang JS, Kwon OK, Kim JE, Kang HS, Park H, Cho SY et al. Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease. Neurosurgery. 2012;70(3):625\u201332; discussion 32\u20133. https:\/\/doi.org\/10.1227\/NEU.0b013e3182333c47.","DOI":"10.1227\/NEU.0b013e3182333c47"},{"issue":"3","key":"318_CR182","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00701-013-1975-7","volume":"156","author":"T Funaki","year":"2014","unstructured":"Funaki T, Takahashi JC, Takagi Y, Yoshida K, Araki Y, Kikuchi T, et al. Incidence of late cerebrovascular events after direct bypass among children with moyamoya disease: a descriptive longitudinal study at a single center. Acta Neurochir (Wien). 2014;156(3):551\u20139. https:\/\/doi.org\/10.1007\/s00701-013-1975-7.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"318_CR183","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3171\/jns.1992.77.1.0084","volume":"77","author":"J Karasawa","year":"1992","unstructured":"Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 1992;77(1):84\u20139. https:\/\/doi.org\/10.3171\/jns.1992.77.1.0084.","journal-title":"J Neurosurg"},{"issue":"6","key":"318_CR184","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1227\/01.Neu.0000369606.00861.91","volume":"66","author":"S Kuroda","year":"2010","unstructured":"Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 2010;66(6):1093\u2013101. https:\/\/doi.org\/10.1227\/01.Neu.0000369606.00861.91.","journal-title":"Neurosurgery"},{"issue":"2","key":"318_CR185","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00701-012-1545-4","volume":"155","author":"BA Gross","year":"2013","unstructured":"Gross BA, Du R. Adult moyamoya after revascularization. Acta Neurochir (Wien). 2013;155(2):247\u201354. https:\/\/doi.org\/10.1007\/s00701-012-1545-4.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"318_CR186","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000369524","volume":"39","author":"XY Bao","year":"2015","unstructured":"Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, et al. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovasc Dis. 2015;39(2):75\u201381. https:\/\/doi.org\/10.1159\/000369524.","journal-title":"Cerebrovasc Dis"},{"key":"318_CR187","doi-asserted-by":"publisher","unstructured":"Goda M, Isono M, Ishii K, Kamida T, Abe T, Kobayashi H. Long-term effects of indirect bypass surgery on collateral vessel formation in pediatric moyamoya disease. Journal of neurosurgery. 2004;100(2 Suppl Pediatrics):156\u201362. https:\/\/doi.org\/10.3171\/ped.2004.100.2.0156.","DOI":"10.3171\/ped.2004.100.2.0156"},{"issue":"3","key":"318_CR188","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","volume":"67","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67(3):273\u201382. https:\/\/doi.org\/10.1016\/j.surneu.2006.07.017.","journal-title":"Surg Neurol"},{"issue":"6","key":"318_CR189","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1159\/000132205","volume":"25","author":"JE Kim","year":"2008","unstructured":"Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK. Transient hyperperfusion after superficial temporal artery\/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis. 2008;25(6):580\u20136. https:\/\/doi.org\/10.1159\/000132205.","journal-title":"Cerebrovasc Dis"},{"key":"318_CR190","doi-asserted-by":"publisher","unstructured":"Katsuta T, Inoue T, Arakawa S, Uda K. Cutaneous necrosis after superficial temporal artery-to-middle cerebral artery anastomosis: is it predictable or avoidable? Neurosurgery. 2001;49(4):879\u201382; discussion 82\u20134. https:\/\/doi.org\/10.1097\/00006123-200110000-00019.","DOI":"10.1097\/00006123-200110000-00019"},{"issue":"5","key":"318_CR191","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3171\/2014.12.Jns132602","volume":"123","author":"K Takanari","year":"2015","unstructured":"Takanari K, Araki Y, Okamoto S, Sato H, Yagi S, Toriyama K, et al. Operative wound-related complications after cranial revascularization surgeries. J Neurosurg. 2015;123(5):1145\u201350. https:\/\/doi.org\/10.3171\/2014.12.Jns132602.","journal-title":"J Neurosurg"},{"issue":"8","key":"318_CR192","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/circresaha.116.310277","volume":"120","author":"L Gao","year":"2017","unstructured":"Gao L, Kupfer ME, Jung JP, Yang L, Zhang P, Da Sie Y, et al. Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold. Circ Res. 2017;120(8):1318\u201325. https:\/\/doi.org\/10.1161\/circresaha.116.310277.","journal-title":"Circ Res"},{"key":"318_CR193","first-page":"55","volume":"36","author":"AKO Alstrup","year":"2009","unstructured":"Alstrup AKO, Winterdahl M. Imaging Techniques in Large Animals. Scand J Lab Anim Sci. 2009;36:55\u201366.","journal-title":"Scand J Lab Anim Sci"},{"issue":"4","key":"318_CR194","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024.","journal-title":"Cell"},{"issue":"2","key":"318_CR195","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.stem.2022.12.010","volume":"30","author":"Z \u00c1lvarez","year":"2023","unstructured":"\u00c1lvarez Z, Ortega JA, Sato K, Sasselli IR, Kolberg-Edelbrock AN, Qiu R, et al. Artificial extracellular matrix scaffolds of mobile molecules enhance maturation of human stem cell-derived neurons. Cell Stem Cell. 2023;30(2):219-38.e14. https:\/\/doi.org\/10.1016\/j.stem.2022.12.010.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"318_CR196","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.stemcr.2023.03.016","volume":"18","author":"AH Laperle","year":"2023","unstructured":"Laperle AH, Moser VA, Avalos P, Lu B, Wu A, Fulton A, et al. Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration. Stem Cell Reports. 2023;18(8):1629\u201342. https:\/\/doi.org\/10.1016\/j.stemcr.2023.03.016.","journal-title":"Stem Cell Reports"},{"issue":"8","key":"318_CR197","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/circulationaha.123.064876","volume":"150","author":"H Kobayashi","year":"2024","unstructured":"Kobayashi H, Tohyama S, Ichimura H, Ohashi N, Chino S, Soma Y, et al. Regeneration of nonhuman primate hearts with human induced pluripotent stem cell-derived cardiac spheroids. Circulation. 2024;150(8):611\u201321. https:\/\/doi.org\/10.1161\/circulationaha.123.064876.","journal-title":"Circulation"},{"issue":"1","key":"318_CR198","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41421-022-00446-7","volume":"8","author":"L Li","year":"2022","unstructured":"Li L, Wan Z, Wang R, Zhao Y, Ye Y, Yang P, et al. Generation of high-performance human cardiomyocytes and engineered heart tissues from extended pluripotent stem cells. Cell discovery. 2022;8(1):105. https:\/\/doi.org\/10.1038\/s41421-022-00446-7.","journal-title":"Cell discovery"},{"issue":"1","key":"318_CR199","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41421-024-00662-3","volume":"10","author":"J Wu","year":"2024","unstructured":"Wu J, Li T, Guo M, Ji J, Meng X, Fu T, et al. Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue. Cell discovery. 2024;10(1):45. https:\/\/doi.org\/10.1038\/s41421-024-00662-3.","journal-title":"Cell discovery"},{"issue":"3","key":"318_CR200","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y, et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports. 2014;2(3):337\u201350. https:\/\/doi.org\/10.1016\/j.stemcr.2014.01.013.","journal-title":"Stem Cell Reports"},{"issue":"5","key":"318_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173222","volume":"12","author":"SV Rojas","year":"2017","unstructured":"Rojas SV, Kensah G, Rotaermel A, Baraki H, Kutschka I, Zweigerdt R, et al. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction. PLoS ONE. 2017;12(5):e0173222. https:\/\/doi.org\/10.1371\/journal.pone.0173222.","journal-title":"PLoS ONE"},{"issue":"8","key":"318_CR202","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.stem.2024.06.001","volume":"31","author":"N Saurat","year":"2024","unstructured":"Saurat N, Minotti AP, Rahman MT, Sikder T, Zhang C, Cornacchia D, et al. Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration. Cell Stem Cell. 2024;31(8):1162-74.e8. https:\/\/doi.org\/10.1016\/j.stem.2024.06.001.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"318_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305","volume":"29","author":"K Tokairin","year":"2020","unstructured":"Tokairin K, Hamauchi S, Ito M, Kazumata K, Sugiyama T, Nakayama N, et al. Vascular smooth muscle cell derived from IPS cell of Moyamoya disease - comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovasc Dis. 2020;29(12):105305. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105305.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"318_CR204","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nbt.2107","volume":"30","author":"C Cheung","year":"2012","unstructured":"Cheung C, Bernardo AS, Trotter MW, Pedersen RA, Sinha S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol. 2012;30(2):165\u201373. https:\/\/doi.org\/10.1038\/nbt.2107.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"318_CR205","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3171\/2013.9.Jns131000","volume":"120","author":"HS Kang","year":"2014","unstructured":"Kang HS, Moon YJ, Kim YY, Park WY, Park AK, Wang KC, et al. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model. J Neurosurg. 2014;120(2):415\u201325. https:\/\/doi.org\/10.3171\/2013.9.Jns131000.","journal-title":"J Neurosurg"},{"issue":"9","key":"318_CR206","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163561","volume":"11","author":"S Hamauchi","year":"2016","unstructured":"Hamauchi S, Shichinohe H, Uchino H, Yamaguchi S, Nakayama N, Kazumata K, et al. Cellular functions and gene and protein expression profiles in endothelial cells derived from Moyamoya disease-specific iPS cells. PLoS ONE. 2016;11(9):e0163561. https:\/\/doi.org\/10.1371\/journal.pone.0163561.","journal-title":"PLoS ONE"},{"issue":"9\u201310","key":"318_CR207","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/0963689719863784","volume":"28","author":"NG Toman","year":"2019","unstructured":"Toman NG, Grande AW, Low WC. Neural Repair in Stroke. Cell Transplant. 2019;28(9\u201310):1123\u20136. https:\/\/doi.org\/10.1177\/0963689719863784.","journal-title":"Cell Transplant"},{"issue":"14","key":"318_CR208","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl4370","volume":"8","author":"GL Sequiera","year":"2022","unstructured":"Sequiera GL, Srivastava A, Sareen N, Yan W, Alagarsamy KN, Verma E, et al. Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. Sci Adv. 2022;8(14):eabl4370. https:\/\/doi.org\/10.1126\/sciadv.abl4370.","journal-title":"Sci Adv"},{"key":"318_CR209","doi-asserted-by":"publisher","unstructured":"Lester Sequiera G, Srivastava A, Alagarsamy KN, Rockman-Greenberg C, Dhingra S. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome. Cells. 2021;10(3). https:\/\/doi.org\/10.3390\/cells10030568.","DOI":"10.3390\/cells10030568"},{"key":"318_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101509","volume":"39","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li A, Huang CL, Wang G, Wang D. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A. Stem Cell Res. 2019;39:101509. https:\/\/doi.org\/10.1016\/j.scr.2019.101509.","journal-title":"Stem Cell Res"},{"key":"318_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101621","volume":"41","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li A, Wang J, Wang G, Wang D. Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene. Stem Cell Res. 2019;41:101621. https:\/\/doi.org\/10.1016\/j.scr.2019.101621.","journal-title":"Stem Cell Res"},{"issue":"2","key":"318_CR212","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15283\/ijsc17019","volume":"10","author":"M Sadat-Ali","year":"2017","unstructured":"Sadat-Ali M, Azam MQ, Elshabouri EM, Tantawy AM, Acharya S. Stem cell therapy for avascular necrosis of femoral head in sickle cell disease: report of 11 cases and review of literature. Int J Stem Cells. 2017;10(2):179\u201383. https:\/\/doi.org\/10.15283\/ijsc17019.","journal-title":"Int J Stem Cells"},{"issue":"6746","key":"318_CR213","doi-asserted-by":"publisher","DOI":"10.1126\/science.adv9789","volume":"388","author":"G Faure","year":"2025","unstructured":"Faure G, Saito M, Wilkinson ME, Quinones-Olvera N, Xu P, Flam-Shepherd D, et al. TIGR-tas: a family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses. Science. 2025;388(6746):eadv9789. https:\/\/doi.org\/10.1126\/science.adv9789.","journal-title":"Science"},{"issue":"9","key":"318_CR214","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","volume":"21","author":"CJ Bashor","year":"2022","unstructured":"Bashor CJ, Hilton IB, Bandukwala H, Smith DM, Veiseh O. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discovery. 2022;21(9):655\u201375. https:\/\/doi.org\/10.1038\/s41573-022-00476-6.","journal-title":"Nat Rev Drug Discovery"},{"issue":"7629","key":"318_CR215","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, et al. CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539(7629):384\u20139. https:\/\/doi.org\/10.1038\/nature20134.","journal-title":"Nature"},{"issue":"9","key":"318_CR216","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa2215643","volume":"389","author":"A Sharma","year":"2023","unstructured":"Sharma A, Boelens JJ, Cancio M, Hankins JS, Bhad P, Azizy M, et al. CRISPR-Cas9 editing of the HBG1 and HBG2 promoters to treat sickle cell disease. N Engl J Med. 2023;389(9):820\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2215643.","journal-title":"N Engl J Med"},{"issue":"4","key":"318_CR217","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"36","author":"L da Cruz","year":"2018","unstructured":"da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018;36(4):328\u201337. https:\/\/doi.org\/10.1038\/nbt.4114.","journal-title":"Nat Biotechnol"},{"key":"318_CR218","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fncel.2019.00297","volume":"13","author":"H Bogetofte","year":"2019","unstructured":"Bogetofte H, Jensen P, Ryding M, Schmidt SI, Okarmus J, Ritter L, et al. PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons. Front Cell Neurosci. 2019;13:297. https:\/\/doi.org\/10.3389\/fncel.2019.00297.","journal-title":"Front Cell Neurosci"},{"issue":"22","key":"318_CR219","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/circulationaha.121.054628","volume":"144","author":"J Li","year":"2021","unstructured":"Li J, Wang K, Zhang Y, Qi T, Yuan J, Zhang L, et al. Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo. Circulation. 2021;144(22):1760\u201376. https:\/\/doi.org\/10.1161\/circulationaha.121.054628.","journal-title":"Circulation"},{"issue":"757","key":"318_CR220","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg0338","volume":"16","author":"T Tadokoro","year":"2024","unstructured":"Tadokoro T, Murata S, Kato M, Ueno Y, Tsuchida T, Okumura A, et al. Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation. Sci Transl Med. 2024;16(757):eadg0338. https:\/\/doi.org\/10.1126\/scitranslmed.adg0338.","journal-title":"Sci Transl Med"},{"issue":"11","key":"318_CR221","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/s41380-024-02629-y","volume":"29","author":"C Zivko","year":"2024","unstructured":"Zivko C, Sagar R, Xydia A, Lopez-Montes A, Mintzer J, Rosenberg PB, et al. Ipsc-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer\u2019s disease. Mol Psychiatry. 2024;29(11):3644\u201352. https:\/\/doi.org\/10.1038\/s41380-024-02629-y.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"318_CR222","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.stem.2024.06.009","volume":"31","author":"JL Thangaraj","year":"2024","unstructured":"Thangaraj JL, Coffey M, Lopez E, Kaufman DS. Disruption of TGF-\u03b2 signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells. Cell Stem Cell. 2024;31(9):1327-43.e5. https:\/\/doi.org\/10.1016\/j.stem.2024.06.009.","journal-title":"Cell Stem Cell"},{"key":"318_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101881","volume":"47","author":"E Romano","year":"2020","unstructured":"Romano E, Trionfini P, Ciampi O, Benigni A, Tomasoni S. Generation of PKD1 mono-allelic and bi-allelic knockout iPS cell lines using CRISPR-Cas9 system. Stem Cell Res. 2020;47:101881. https:\/\/doi.org\/10.1016\/j.scr.2020.101881.","journal-title":"Stem Cell Res"},{"key":"318_CR224","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1038\/mtna.2015.42","volume":"4","author":"H Kang","year":"2015","unstructured":"Kang H, Minder P, Park MA, Mesquitta WT, Torbett BE, Slukvin II. CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus. Mol Ther Nucleic Acids. 2015;4:e268. https:\/\/doi.org\/10.1038\/mtna.2015.42.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"318_CR225","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40824-023-00381-y","volume":"27","author":"P Pinjala","year":"2023","unstructured":"Pinjala P, Tryphena KP, Prasad R, Khatri DK, Sun W, Singh SB, et al. CRISPR\/Cas9 assisted stem cell therapy in Parkinson\u2019s disease. Biomaterials Research. 2023;27(1):46. https:\/\/doi.org\/10.1186\/s40824-023-00381-y.","journal-title":"Biomaterials Research"},{"issue":"5","key":"318_CR226","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discovery. 2019;18(5):358\u201378. https:\/\/doi.org\/10.1038\/s41573-019-0012-9.","journal-title":"Nat Rev Drug Discovery"},{"issue":"7","key":"318_CR227","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38(7):824\u201344. https:\/\/doi.org\/10.1038\/s41587-020-0561-9.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"318_CR228","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41551-020-00671-z","volume":"5","author":"L Villiger","year":"2021","unstructured":"Villiger L, Rothgangl T, Witzigmann D, Oka R, Lin PJC, Qi W, et al. In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA. Nat Biomed Eng. 2021;5(2):179\u201389. https:\/\/doi.org\/10.1038\/s41551-020-00671-z.","journal-title":"Nat Biomed Eng"},{"issue":"4","key":"318_CR229","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.4.3","volume":"11","author":"ME McClements","year":"2022","unstructured":"McClements ME, Steward H, Atkin W, Goode EA, G\u00e1ndara C, Chichagova V, et al. Tropism of AAV vectors in photoreceptor-like cells of human iPSC-derived retinal organoids. Transl Vis Sci Technol. 2022;11(4):3. https:\/\/doi.org\/10.1167\/tvst.11.4.3.","journal-title":"Transl Vis Sci Technol"},{"key":"318_CR230","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.omtm.2021.05.014","volume":"22","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Nishiyama T, Li H, Huang J, Atmanli A, Sanchez-Ortiz E, et al. A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation. Mol Ther Methods Clin Dev. 2021;22:122\u201332. https:\/\/doi.org\/10.1016\/j.omtm.2021.05.014.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"318_CR231","doi-asserted-by":"publisher","first-page":"14454","DOI":"10.1038\/ncomms14454","volume":"8","author":"NE Bengtsson","year":"2017","unstructured":"Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, et al. Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat Commun. 2017;8:14454. https:\/\/doi.org\/10.1038\/ncomms14454.","journal-title":"Nat Commun"},{"issue":"8","key":"318_CR232","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","volume":"40","author":"AD Nahmad","year":"2022","unstructured":"Nahmad AD, Lazzarotto CR, Zelikson N, Kustin T, Tenuta M, Huang D, et al. In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nat Biotechnol. 2022;40(8):1241\u20139. https:\/\/doi.org\/10.1038\/s41587-022-01328-9.","journal-title":"Nat Biotechnol"},{"issue":"7681","key":"318_CR233","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature. 2017;551(7681):464\u201371. https:\/\/doi.org\/10.1038\/nature24644.","journal-title":"Nature"},{"issue":"11","key":"318_CR234","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s13238-017-0475-6","volume":"8","author":"P Liang","year":"2017","unstructured":"Liang P, Ding C, Sun H, Xie X, Xu Y, Zhang X, et al. Correction of \u03b2-thalassemia mutant by base editor in human embryos. Protein Cell. 2017;8(11):811\u201322. https:\/\/doi.org\/10.1007\/s13238-017-0475-6.","journal-title":"Protein Cell"},{"issue":"1","key":"318_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35508-7","volume":"14","author":"J Liao","year":"2023","unstructured":"Liao J, Chen S, Hsiao S, Jiang Y, Yang Y, Zhang Y, et al. Therapeutic adenine base editing of human hematopoietic stem cells. Nat Commun. 2023;14(1):207. https:\/\/doi.org\/10.1038\/s41467-022-35508-7.","journal-title":"Nat Commun"},{"issue":"16","key":"318_CR236","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","volume":"70","author":"S Xu","year":"2013","unstructured":"Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci. 2013;70(16):2859\u201372. https:\/\/doi.org\/10.1007\/s00018-012-1194-z.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"318_CR237","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1124\/mol.110.068064","volume":"79","author":"N Matsunaga","year":"2011","unstructured":"Matsunaga N, Tsuchimori N, Matsumoto T, Ii M. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol. 2011;79(1):34\u201341. https:\/\/doi.org\/10.1124\/mol.110.068064.","journal-title":"Mol Pharmacol"},{"key":"318_CR238","doi-asserted-by":"publisher","DOI":"10.3390\/cells14110775","author":"J Choi","year":"2025","unstructured":"Choi J, Inoue R, Masuo Y, Shimizu Y, Sonomura K, Kim M, et al. RNF213 acts as a molecular switch for Cav-1 ubiquitination and phosphorylation in human cells. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14110775.","journal-title":"Cells"},{"issue":"8","key":"318_CR239","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1242\/dev.092304","volume":"140","author":"B Cristofaro","year":"2013","unstructured":"Cristofaro B, Shi Y, Faria M, Suchting S, Leroyer AS, Trindade A, et al. Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models. Development. 2013;140(8):1720\u20139. https:\/\/doi.org\/10.1242\/dev.092304.","journal-title":"Development"},{"key":"318_CR240","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0474-19.2020","author":"T Shibahara","year":"2020","unstructured":"Shibahara T, Ago T, Nakamura K, Tachibana M, Yoshikawa Y, Komori M, et al. Pericyte-mediated tissue repair through PDGFR\u03b2 promotes peri-infarct astrogliosis, oligodendrogenesis, and functional recovery after acute ischemic stroke. eNeuro. 2020. https:\/\/doi.org\/10.1523\/eneuro.0474-19.2020.","journal-title":"eNeuro"},{"issue":"26","key":"318_CR241","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1182\/blood-2013-03-490763","volume":"121","author":"J Ruan","year":"2013","unstructured":"Ruan J, Luo M, Wang C, Fan L, Yang SN, Cardenas M, et al. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood. 2013;121(26):5192\u2013202. https:\/\/doi.org\/10.1182\/blood-2013-03-490763.","journal-title":"Blood"},{"issue":"1","key":"318_CR242","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41232-022-00223-9","volume":"42","author":"F Yao","year":"2022","unstructured":"Yao F, Luo Y, Liu YC, Chen YH, Li YT, Hu XY, et al. Imatinib inhibits pericyte-fibroblast transition and inflammation and promotes axon regeneration by blocking the PDGF-BB\/PDGFR\u03b2 pathway in spinal cord injury. Inflamm Regen. 2022;42(1):44. https:\/\/doi.org\/10.1186\/s41232-022-00223-9.","journal-title":"Inflamm Regen"},{"issue":"5","key":"318_CR243","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.017701","volume":"10","author":"WK Seo","year":"2021","unstructured":"Seo WK, Kim JY, Choi EH, Kim YS, Chung JW, Saver JL, et al. Association of antiplatelet therapy, including cilostazol, with improved survival in patients with Moyamoya disease in a nationwide study. J Am Heart Assoc. 2021;10(5):e017701. https:\/\/doi.org\/10.1161\/jaha.120.017701.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"318_CR244","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12519-024-00824-z","volume":"20","author":"SF Huang","year":"2024","unstructured":"Huang SF, Xu JL, Ren CH, Sim N, Han C, Han YQ, et al. Remote ischemic conditioning prevents ischemic cerebrovascular events in children with moyamoya disease: a randomized controlled trial. World J Pediatr. 2024;20(9):925\u201334. https:\/\/doi.org\/10.1007\/s12519-024-00824-z.","journal-title":"World J Pediatr"},{"key":"318_CR245","doi-asserted-by":"publisher","first-page":"1200534","DOI":"10.3389\/fneur.2023.1200534","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang H, Hu Z, Gao X, Su J, Jiang H, Yang S, et al. Safety and efficacy of remote ischemic conditioning in adult moyamoya disease patients undergoing revascularization surgery: a pilot study. Front Neurol. 2023;14:1200534. https:\/\/doi.org\/10.3389\/fneur.2023.1200534.","journal-title":"Front Neurol"},{"issue":"2","key":"318_CR246","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1227\/neu.0000000000000238","volume":"74","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, et al. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery. 2014;74(2):163\u201370. https:\/\/doi.org\/10.1227\/neu.0000000000000238.","journal-title":"Neurosurgery"},{"key":"318_CR247","unstructured":"Phase I Clinical Trial of Induced Pluripotent Stem Cell-derived Extracellular Vesicles Combined With Temporal Muscle Flap Application in Promoting Intracranial and Extracranial Blood Flow Reconstruction in Patients With Moyamoya Disease [database on the Internet]2025. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07065409. Accessed:"},{"issue":"5","key":"318_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26748","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Chen C, Qin X, Wang J, Zhang B, Jin F. Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease. Heliyon. 2024;10(5):e26748. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26748.","journal-title":"Heliyon"},{"key":"318_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.548278","volume":"14","author":"G Wang","year":"2020","unstructured":"Wang G, Wen Y, Faleti OD, Zhao Q, Liu J, Zhang G, et al. A panel of exosome-derived miRNAs of cerebrospinal fluid for the diagnosis of Moyamoya disease. Front Neurosci. 2020;14:548278. https:\/\/doi.org\/10.3389\/fnins.2020.548278.","journal-title":"Front Neurosci"},{"issue":"4","key":"318_CR250","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2014.01.005","volume":"156","author":"K Ohnishi","year":"2014","unstructured":"Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 2014;156(4):663\u201377. https:\/\/doi.org\/10.1016\/j.cell.2014.01.005.","journal-title":"Cell"},{"issue":"12","key":"318_CR251","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1242\/dev.092551","volume":"140","author":"K Takahashi","year":"2013","unstructured":"Takahashi K, Yamanaka S. Induced pluripotent stem cells in medicine and biology. Development. 2013;140(12):2457\u201361. https:\/\/doi.org\/10.1242\/dev.092551.","journal-title":"Development"},{"issue":"4","key":"318_CR252","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrc3034","volume":"11","author":"U Ben-David","year":"2011","unstructured":"Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11(4):268\u201377. https:\/\/doi.org\/10.1038\/nrc3034.","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:47:50Z","timestamp":1760064470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":252,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00318-y","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}